The biosensor detection platform will simplify and expand the use of biomolecule analysis through easy-to-use.

It provide routine access to critical information by simplifying conventional test protocols for medical professionals. Current laboratory-based test methods are complex, take up too much space, have a high cost and require a high level of supervision are time-consuming, and expensive which limits access to quantitative, time-sensitive diagnostic information.

Detection devices made with random networks of carbon nanotubes are ultra sensitive and inexpensive to produce.

Single or multianalyte detection is performed using the biosensor platform with minimal sample pre-treatment. No target amplification, such as PCR, will be required for the detection platform.

These sensors would be suitable for sensing different species of interest. Such sensors could be configured in the form of an array to comprehensively and cost-effectively monitor multiple species.

• Has high specificity and reproducibility with the ability to select a desired dynamic range.

• Enables measurement of small changes in electronic characteristics, allowing ultra-sensitive detection.

• Eliminates the need for expensive labeling chemistries and optical equipment.

• Provides for detection of nucleic acids and proteins.

• Provides multiplex capabilities in a simple on-chip assay.

• DNA: Direct, label free electronic detection. Applications include electronic detection of Genetically Modified Organisms (GMO) in samples, and detection of human genetic patterns for diagnosis of infectious diseases, inherited diseases, and drug metabolism.

• Protein: Multiple proteins are detected in sub ng/ml concentration levels using highly specific antibody chemistry on the same platform detection device. A wide variety of high value point-of-care applications exist including the diagnosis of conditions such as detection of biomarkers and diagnosis of pregnancy through hormone detection, cancer, etc.